Gene · 7148
Papers1,502
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,502
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Molecular characterization of extracellular vesicles derived from follicular fluid of women with and without PCOS: integrating analysis of differential miRNAs and proteins reveals vital molecules involving in PCOS. | J Assist Reprod Genet | 2023 | 36695944 | PubTator, text mining | PubMed |
| A Homozygous PPP1R21 Splice Variant Associated with Severe Developmental Delay, Absence of Speech, and Muscle Weakness Leads to Activated Proteasome Function. | Mol Neurobiol | 2023 | 36692708 | PubTator, text mining | PubMed |
| Why do humans need thrombospondin-1? | J Cell Commun Signal | 2023 | 36689135 | PubTator, text mining | PubMed |
| Adipose Tissue-Derived Extracellular Vesicles Contribute to Phenotypic Plasticity of Prostate Cancer Cells. | Int J Mol Sci | 2023 | 36674745 | PubTator, text mining | PubMed |
| Disease- and sex-specific differences in patients with heart valve disease: a proteome study. | Life Sci Alliance | 2023 | 36627164 | PubTator, text mining | PubMed |
| Patient-specific identification of genome-wide DNA-methylation differences between intracranial and extracranial melanoma metastases. | Sci Rep | 2023 | 36624125 | PubTator, text mining | PubMed |
| Candidate Biological Markers for Social Anxiety Disorder: A Systematic Review. | Int J Mol Sci | 2023 | 36614278 | PubTator, text mining | PubMed |
| Epigenetic drugs in somatostatin type 2 receptor radionuclide theranostics and radiation transcriptomics in mouse pheochromocytoma models. | Theranostics | 2023 | 36593963 | PubTator, text mining | PubMed |
| Regional and disease specific human lung extracellular matrix composition. | Biomaterials | 2023 | 36580718 | PubTator, text mining | PubMed |
| Integrated proteome and phosphoproteome analysis of gastric adenocarcinoma reveals molecular signatures capable of stratifying patient outcome. | Mol Oncol | 2023 | 36520032 | PubTator, text mining | PubMed |
| Extracellular matrix in skin diseases: The road to new therapies. | J Adv Res | 2023 | 36481476 | PubTator, text mining | PubMed |
| High expression of COL6A1 predicts poor prognosis and response to immunotherapy in bladder cancer. | Cell Cycle | 2023 | 36474424 | PubTator, text mining | PubMed |
| Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene. | Hormones (Athens) | 2023 | 36264454 | PubTator, text mining | PubMed |
| Congenital adrenal hyperplasia with a CYP21A2 deletion overlapping the tenascin-X gene: an atypical presentation. | J Pediatr Endocrinol Metab | 2023 | 36259452 | PubTator, text mining | PubMed |
| Enrichment of Patients With Ehlers Danlos Syndrome in Idiopathic Gastroparesis-A Gene Set Enrichment Analysis. | Clin Transl Gastroenterol | 2023 | 36000988 | PubTator, text mining | PubMed |
| Low expression of NR1H3 correlates with macrophage infiltration and indicates worse survival in breast cancer. | Front Genet | 2022 | 36699456 | PubTator, text mining | PubMed |
| Deep Venous Thrombosis and Pulmonary Thromboembolism Associated With Retroperitoneal Hematoma in a Patient With Ehlers-Danlos Syndrome Type VI. | Cureus | 2022 | 36686105 | PubTator, text mining | PubMed |
| Pathways Activated by Infected and Bystander Chondrocytes in Response to Ross River Virus Infection. | Viruses | 2022 | 36680176 | PubTator, text mining | PubMed |
| Age- and Stage-Dependent Prostate Cancer Aggressiveness Associated with Differential Notch Signaling. | Int J Mol Sci | 2022 | 36613607 | PubTator, text mining | PubMed |
| Expanding the Etiology of Oculo-Auriculo-Vertebral Spectrum: A Novel Interstitial Microdeletion at 1p36. | Int J Mol Sci | 2022 | 36613479 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7148/papers?page=13